Page 44 - Read Online

Page 12 of 14 Bittoni et al. J Cancer Metastasis Treat 2018;4:55 I http://dx.doi.org/10.20517/2394-4722.2018.37

Manuscript editing: Meletani T, Sotte V, Cantini L, Giampieri R, Bittoni A
Manuscript revision: Berardi R, Bittoni A, Meletani T, Sotte V, Cantini L, Giampieri R

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, et al. ESMO consensus guidelines for the management of patients with
metastatic colorectal cancer. Ann Oncol 2016;27:1386-422.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
3. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008;135:1079-99.
4. de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010;28:3380-7.
5. de Weger VA, Turksma AW, Voorham QJ, Euler Z, Bril H, et al. Clinical effects of adjuvant active specific immunotherapy differ between
patients with microsatellite-stable and microsatellite-instable colon cancer. Clin Cancer Res 2012;18:882-9.
6. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. A National Cancer Institute Workshop on microsatellite
instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite
instability in colorectal cancer. Cancer Res 1998;58:5248-57.
7. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of
chromosomal instability. Gastroenterology 2002;123:1109-19.
8. Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, et al. Progression from colorectal adenoma to carcinoma is associated
with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998;51:901-9.
9. Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, et al. Microsatellite instability has a positive prognostic impact on stage II
colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol 2013;24:1274-82.
10. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, et al. Microsatellite instability in sporadic colon cancer is associated with an
improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917-23.
11. Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a
review. Cancer Treat Rev 2016;51:19-26.
12. Segal NH, Parsons DW, Peggs KS, Velculescu V, Kinzler KW, et al. Epitope landscape in breast and colorectal cancer. Cancer Res
2008;68:889-92.
13. Roelands J, Kuppen PJK, Vermeulen L, Maccalli C, Decock J, et al. Immunogenomic classification of colorectal cancer and therapeutic
implications. Int J Mol Sci 2017; doi: 10.3390/ijms18102229.
14. Voena C, Chiarle R. Advances in cancer immunology and cancer immunotherapy. Discov Med 2016;21:125-133.
15. Schiavoni G, Gabriele L, Mattei F. The tumor microenvironment: apitch for multiple players. Front Oncol 2013;3:90.
16. Herrera M, Herrera A, Domínguez G, Silva J, García V, et al. Cancer-associated fibroblast and M2 macrophage markers together predict
outcome in colorectal cancer patients. Cancer Sci 2013;104:437-44.
17. Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, et al. Immunotherapy for colorectal cancer: where are we heading? Expert
Opin Biol Ther 2017;17:709-21.
18. Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, et al. In situ cytotoxic and memory T cells predict outcome in patients with
early-stage colorectal cancer. J Clin Oncol 2009;27:5944-51.
19. Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, et al. Histopathologic-based prognostic factors of colorectal cancers are
associated with the state of the local immune reaction. J Clin Oncol 2011;29:610-8.